Related Experiment Video
Updated: Dec 20, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
Yuqing Pei1, Kexin Li1, Xiaoying Lou1
1State Key Laboratory of Molecular Oncology, Department of Clinical Laboratory, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.
Abstract:
Recent studies have revealed the oncogenic role of notch reporter 3 (NOTCH3) in ovarian cancer (OC). However, the possible regulators and mechanisms underlying notch receptor 3 (NOTCH3)‑mediated behaviors in OC remain to be completely investigated. In the present study, we aimed to identify regulators of NOTCH3 and their interactions underlying the pathogenesis of OC. Bioinformatics analysis and luciferase reporter assay were used to identify potential regulatory miRNAs and lncRNAs of NOTCH3 in OC. Several in vivo and in vitro assays were performed to evaluate their effects on the proliferative ability mediated by NOTCH3. We identified microRNA‑1299 (miR‑1299) as a novel negative regulator of NOTCH3. miR‑1299 was downregulated in OC and was found to be considerably correlated with tumor differentiation. Upregulation of miR‑1299 inhibited cell proliferation, colony formation, and 5‑ethynyl‑2'‑deoxyuridine (EdU) incorporation, as well as induced cell cycle arrest in the G0G1 phase in OC cells. Overexpression of miR‑1299 in xenograft mouse models suppressed tumor growth in vivo. The lncRNA taurine upregulated gene 1 (TUG1), acting as a sponge of miR‑1299, was found to upregulate NOTCH3 expression and promote cell proliferation in OC through the competing endogenous RNA mechanism. In addition, TUG1 was found to be a potential downstream target of NOTCH3, forming a miR‑1299/NOTCH3/TUG1 feedback loop in the development of OC. Collectively, our findings improve the understanding of NOTCH3‑mediated regulation in OC pathogenesis and facilitate the development of miRNA‑ and lncRNA‑directed diagnostics and therapeutics against this disease.
Insights
MicroRNA-1299 (miR-1299) inhibits ovarian cancer (OC) progression by downregulating NOTCH3. This study reveals a miR-1299/NOTCH3/TUG1 feedback loop, offering potential therapeutic targets for OC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Notch receptor 3 (NOTCH3) plays an oncogenic role in ovarian cancer (OC).
- The precise regulatory mechanisms of NOTCH3 in OC pathogenesis require further elucidation.
- Identifying novel regulators and pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To identify microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) that regulate NOTCH3 in OC.
- To investigate the functional role of identified regulators in OC cell proliferation and tumor growth.
- To explore the underlying molecular mechanisms, including potential feedback loops, involving NOTCH3, miRNAs, and lncRNAs in OC.
Main Methods:
- Bioinformatics analysis and luciferase reporter assays to identify regulatory miRNAs and lncRNAs.
- In vitro assays (cell proliferation, colony formation, EdU incorporation, cell cycle analysis) to assess functional effects.
- In vivo xenograft mouse models to evaluate tumor growth suppression.
Main Results:
- MicroRNA-1299 (miR-1299) was identified as a direct negative regulator of NOTCH3, downregulated in OC.
- Overexpression of miR-1299 inhibited OC cell proliferation, colony formation, and induced G0G1 cell cycle arrest, suppressing tumor growth in vivo.
- Long non-coding RNA taurine upregulated gene 1 (TUG1) acts as a sponge for miR-1299, upregulating NOTCH3 and promoting proliferation.
- A feedback loop involving miR-1299, NOTCH3, and TUG1 was identified in OC development.
Conclusions:
- miR-1299 functions as a tumor suppressor in OC by targeting NOTCH3.
- The lncRNA TUG1 promotes OC progression via the competing endogenous RNA mechanism involving miR-1299 and NOTCH3.
- The identified miR-1299/NOTCH3/TUG1 feedback loop provides novel insights into OC pathogenesis and potential therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
PI3K/mTOR/AKT Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Abnormal Proliferation
Canonical Wnt Signaling Pathway

